Aldosterone increases VEGF-A production in human neutrophils through PI3K, ERK1/2 and p38 pathways

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 12, 2011, Pages 2125-2132

  Walczak, Cécile ^a   Gaignier, Fanny ^a   Gilet, Alexandre ^a   Zou, Feng ^a   Thornton, Simon N ^a   Ropars, Armelle ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Aldosterone; Angiogenesis; Neutrophil; Signal transduction; VEGF A

Indexed keywords

ALDOSTERONE; MESSENGER RNA; MINERALOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; SPIRONOLACTONE; SYNAPTOPHYSIN; VASCULOTROPIN A;

ARTICLE; CELL LINE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; INCUBATION TIME; LEUKOCYTE ACTIVATION; NEUTROPHIL; PRIORITY JOURNAL; PROMYELOCYTE; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ALDOSTERONE; BLOTTING, WESTERN; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEUTROPHILS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHATIDYLINOSITOL 3-KINASES; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 82555165003     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.07.010     Document Type: Article

References (40)

1. Brilla C.G., Weber K.T. Mineralocorticoid excess, dietary sodium, and myocardial fibrosis. J. Lab. Clin. Med. 1992, 120:893-901.
2. Sun Y., Zhang J., Lu L., Chen S.S., Quinn M.T., Weber K.T. Aldosterone-induced inflammation in the rat heart: role of oxidative stress. Am. J. Pathol. 2002, 161:1773-1781.
3. Rocha R., Chander P.N., Zuckerman A., Jr Stier C.T. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999, 33:232-237.
4. Blasi E.R., Rocha R., Rudolph A.E., Blomme E.A., Polly M.L., McMahon E.G. Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats. Kidney Int. 2003, 63:1791-1800.
5. Pitt B., Zannad F., Remme W.J., Cody R., Castaigne A., Perez A., Palensky J., Wittes J. The effects of spironolactone on morbidity and mortality in patients with severe heart failure. N. Engl. J. Med. 1999, 341:709-717.
6. Fraccarollo D., Galuppo P., Schraut S., Kneitz S., van Rooijen N., Ertl G., Bauersachs J. Immediate mineralocorticoid receptor blockade improves myocardial infarct healing by modulation of the inflammatory response. Hypertension 2008, 51:905-914.
7. Rajagopalan S., Duquaine D., King S., Pitt B., Patel P. Mineralocorticoid receptor antagonism in experimental atherosclerosis. Circulation 2002, 105:2212-2216.
8. Takai S., Jin D., Muramatsu M., Kirimura K., Sakonjo H., Miyazaki M. Eplerenone inhibits atherosclerosis in nonhuman primates. Hypertension 2005, 46:1135-1139.
9. Krug A.W., Kopprasch S., Ziegler C.G., Dippong S., Catar R.A., Bornstein S.R., Morawietz H., Gekle M. Aldosterone rapidly induces leukocyte adhesion to endothelial cells: a new link between aldosterone and arteriosclerosis?. Hypertension 2007, 50:e156-e157.
10. Caprio M., Newfell B.G., LaSala A., Baur W.E., Fabbri A., Rosano G., Mendelsohn M.E., Jaffe I.Z. Functional mineralocorticoid receptors in human vascular endothelial cells regulate ICAM-1 expression and promote leukocyte adhesion. Circ. Res. 2008, 102:1359-1367.
11. Hashikabe Y., Suzuki K., Jojima T., Uchida K., Hattori Y. Aldosterone impairs vascular endothelial cell function. J. Cardiovasc. Pharmacol. 2006, 47:609-613.
12. Oberleithner H. Aldosterone makes human endothelium stiff and vulnerable. Kidney Int. 2005, 67:1680-1682.
13. Callera G.E., Touyz R.M., Tostes R.C., Yogi A., He Y., Malkinson S., Schiffrin E.L. Aldosterone activates vascular p38MAP kinase and NADPH oxidase via s-Src. Hypertension 2005, 45:773-779.
14. Ishizawa K., Izawa Y., Ito H., Miki C., Miyata K., Fujita Y., Kanematsu Y., Tsuchiya K., Tamaki T., Nishiyama A., Yoshizumi M. Aldosterone stimulates vascular smooth muscle cell proliferation via big mitogen-activated protein kinase 1 activation. Hypertension 2005, 46:1046-1052.
15. Michel F., Ambroisine M.L., Duriez M., Delcayre C., Levy B.I., Silvestre J.S. Aldosterone enhances ischemia-induced neovascularization through angiotensin II-dependent pathway. Circulation 2004, 109:1933-1937.
16. Jaffe I.Z., Newfell B.G., Aronovitz M., Mohammad N.N., McGraw A.P., Perreault R.E., Ehsan A., Mendelsohn M.E. Placental growth factor mediates aldosterone-dependent vascular injury in mice. J. of Clin. Invest. 2010, 120:3891-3900.
17. Keidar S., Kaplan M., Pavlotzky E., Coleman R., Hayek T., Hamoud S., Aviram M. Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone. Circulation 2004, 109:2213-2220.
18. 2 in peripheral blood mononuclear cells. Circulation 2005, 111:51-57.
19. Rickard A.J., Morgan J., Tesch G., Funder J.W., Fuller P.J., Young M.J. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure. Hypertension 2009, 54:537-543.
20. Usher M.G., Duan S.Z., Ivaschenko C.Y., Frieler R.A., Berger S., Schutz G., Lumeng C.N., Mortensen R.M. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice. J. of Clin. Invest. 2010, 120:3350-3364.
21. Bergmann A., Eulenberg C., Wellner M., Rolle S., Luft F., Kettritz R. Aldosterone abrogates nuclear factor kappaB-mediated tumor necrosis factor alpha production in human neutrophils via the mineralocorticoid receptor. Hypertension 2010, 55:370-379.
22. Witko-Sarsat V., Rieu P., Descamps-Latscha B., Lesavre P., Halbwachs-Mecarelli L. Neutrophils: molecules, functions and pathophysiological aspects. Lab. Invest. 2000, 80:617-653.
23. Grosskreutz C.L., Anand-Apte B., Duplaa C., Quinn T.P., Terman B.I., Zetter B., D'Amore P.A. Vascular endothelial growth factor-induced migration of vascular smooth muscle cells in vitro. Microvasc. Res. 1999, 58:128-136.
24. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P.C., Pan Y.C., Olander J.V., Connolly D.T., Stern D. Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 1990, 172:1535-1545.
25. Zhang H., Issekutz A.C. Growth factor regulation of neutrophil-endothelial cell interactions. J. Leuk. Biol. 2001, 70:225-232.
26. Ancelin M., Chollet-Martin S., Hervé M.A., Legrand C., El Benna J., Perrot-Applanat M. Vascular endothelial growth factor VEGF189 induces human chemotaxis in extravascular tissue via an autocrine amplification mechanism. Lab. Invest. 2004, 84:502-512.
27. Webb N.J., Myers C.R., Watson C.J., Bottomley M.J., Brenchley P.E. Activated human neutrophils express vascular endothelial growth factor. Cytokine 1998, 10:254-257.
28. Collins S.J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 1987, 70:1233-1244.
29. Woolard J., Wang W.Y., Bevan H.S., Qiu Y., Morbidelli L., Pritchard-Jones R.O., Cui T.G., Sugiono M., Waine E., Perrin R., Foster R., Digby-Bell J., Shields J.D., Whittles C.E., Mushens R.E., Gillatt D.A., Ziche M., Harper S.J., Bates D.O. VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression. Cancer Res. 2004, 64:7822-7835.
30. McEneaney V., Dooley R., Harvey B.J., Thomas W. Protein kinase D stabilizes aldosterone-induced ERK1/2 MAP kinase activation in M1 renal cortical collecting duct cells to promote cell proliferation. J Steroid Biochem. Mol. Biol. 2010, 118:18-28.
31. Lee Y.S., Kim J.A., Kim K.L., Jang H.S., Kim J.M., Lee J.Y., Shin I.S., Lee J.S., Suh W., Choi J.H., Jeon E.S., Byun J., Kim D.K. Aldosterone upregulates connective tissue growth factor gene expression via p38 MAPK pathway and mineralocorticoid receptor in ventricular myocytes. J. Korean Med. Sci. 2004, 19:805-811.
32. McCourt M., Wang J.H., Sookhai S., Redmond H.P. Proinflammatory mediators stimulates neutrophil-directed angiogenesis. Arch. Surg. 1999, 134:1325-1331.
33. Ushio-Fukai M., Alexander R.W. Reactive oxygen species as mediators of angiogenesis signaling: role of NAD(P)H oxidase. Mol. Cell. Biochem. 2004, 264:85-97.
34. Grossmann C., Husse B., Mildenberger S., Schreier B., Schuman K., Gekle M. Colocalization of mineralocorticoid and EGF receptor at the plasma membrane. Biochim. Biophys. Acta 2010, 1803:584-590.
35. Gaudry M., Brégerie O., Andrieu V., El Benna J., Pocidalo M.A., Hakim J. Intracellular pool of vascular endothelial growth factor in human neutrophils. Blood 1997, 90:4153-4161.
36. Hawinkels L.J., Zuidwijk K., Verspaget H.W., de Jonge-Muller E., van Duijn W., Ferreira V., Fontijn R.D., David G., Hommes D.W., Lamers C.B., Sier C.F. VEGF release by MMP-9 mediated heparin sulphate cleavage induces colorectal angiogenesis. Eur. J. Cancer. 2008, 44:1904-1913.
37. Raiden S., Giordano M., Andonegui G., Trevani A.S., López D.H., Nahmod V., Geffner J.R. Losartan, a selective inhibitor of subtype AT1 receptors for angiotensin II, inhibits the binding of N-formylmethionyl-leucyl-phenylalanine to neutrophil receptors. J. Pharmacol. Exp. Ther. 1997, 281:624-628.
38. Pupilli C., Lasagni L., Romagnani P., Bellini F., Mannelli M., Misciglia C., Mavilia C., Vellei U., Villari D., Serio M. Angiotensin II stimulates the synthesis and secretion of vascular permeability factor/vascular endothelial growth factor in human mesangial cells. J. Am. Soc. Nephrol. 1999, 10:245-255.
39. Zhao Q., Ishibashi M., Hiasa K., Tan C., Takeshita A., Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodelling. Hypertension 2004, 44:264-270.
40. Lemarié C.A., Simeone S.M., Nikonova A., Ebrahimian T., Deschênes M.E., Coffman T.M., Paradis P., Schiffrin E.L. Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors. Circulation 2009, 105:852-859.